Skip to Content

Glaukos Corp GKOS

Morningstar Rating
$88.82 +0.23 (0.26%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

GKOS is trading at a 17% premium.
Price
$88.85
Fair Value
$78.26
Uncertainty
High
1-Star Price
$937.46
5-Star Price
$58.15
Economic Moat
Htsd
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if GKOS is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$88.59
Day Range
$86.6488.89
52-Week Range
$44.2697.24
Bid/Ask
$60.89 / $112.00
Market Cap
$4.39 Bil
Volume/Avg
853,276 / 699,704

Key Statistics

Price/Earnings (Normalized)
Price/Sales
13.67
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Core
Total Number of Employees
907

Comparables

Valuation

Metric
GKOS
SGHT
RXST
Price/Earnings (Normalized)
Price/Book Value
9.451.5812.55
Price/Sales
13.672.4021.54
Price/Cash Flow
Price/Earnings
GKOS
SGHT
RXST

Financial Strength

Metric
GKOS
SGHT
RXST
Quick Ratio
4.5311.267.05
Current Ratio
5.3412.118.06
Interest Coverage
−9.48−10.68−15.68
Quick Ratio
GKOS
SGHT
RXST

Profitability

Metric
GKOS
SGHT
RXST
Return on Assets (Normalized)
−11.38%−25.25%−19.06%
Return on Equity (Normalized)
−22.25%−33.90%−24.35%
Return on Invested Capital (Normalized)
−12.11%−25.20%−22.41%
Return on Assets
GKOS
SGHT
RXST
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
ABT
Abbott LaboratoriesLfjjbtl$205.8 Bil
SYK
Stryker CorpCdmg$134.3 Bil
MDT
Medtronic PLCHjc$111.0 Bil
BSX
Boston Scientific CorpFjqyyd$98.5 Bil
EW
Edwards Lifesciences CorpKlmytn$51.2 Bil
DXCM
DexCom IncZdpb$46.9 Bil
ZBH
Zimmer Biomet Holdings IncBkf$25.4 Bil
ALGN
Align Technology IncTxslh$23.0 Bil
PHG
Koninklijke Philips NV ADRVdsqqw$18.4 Bil
PODD
Insulet CorpJxqswr$11.8 Bil

Sponsor Center